Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)

    NIH supports later-stage research and development for previously funded small business Phase II projects, bridging the gap to commercialization.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Funder: National Institutes of Health

    Due Dates: January 5, 2027 (Application) | April 5, 2027 (Application) | September 5, 2027 (Application) | January 5, 2028 (Application) | April 5, 2028 (Application) | September 5, 2028 (Application) | January 5, 2029 (Application) | April 5, 2029 (Final application)

    Funding Amounts: Up to $30 million total for up to 4 years, subject to component-specific limits; 100% matching funds required

    Summary: Supports later-stage R&D by previous NIH SBIR/STTR Phase II recipients to bridge the gap to commercialization.

    Key Information: Only U.S. small businesses with a previous NIH Phase II award may apply, within six due dates after that award’s budget period expires.


    Description

    NIH’s Phase IIB Strategic Breakthrough award provides follow-on research and development support for small businesses moving previously funded NIH SBIR or STTR Phase II projects toward commercialization. The R44 program addresses the funding gap that can persist after Phase II, particularly for biomedical technologies requiring regulatory approval, complex manufacturing methods, or development for small markets.

    Projects must contribute to the mission of a participating NIH institute or center. NIH emphasizes strong commercial potential: the likelihood that the technology will become an effective, successful product. Applications may include clinical trials, although projects aligned only with NCATS or ORIP cannot propose trials under this opportunity. Applicants are strongly encouraged to discuss project fit and budgets with program staff before applying.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.